Actively Recruiting
Environmental Factors Associated With Peripheral Neuropathies in French Guiana
Led by Admin CIC · Updated on 2026-01-15
78
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Peripheral neuropathies (PN) affect about 1% of people worldwide, especially older adults, causing problems with walking and chronic pain that reduce quality of life. In French Guiana, researchers think that unknown causes of PN may be linked to exposure to neurotoxic traditional plant remedies, arboviral infections like Zika, Chikungunya, and Dengue, and mercury contamination from illegal gold mining. This study aims to explore how these environmental factors relate to PN, including in people with diabetic neuropathy or chronic idiopathic axonal polyneuropathy. This is a prospective multicenter case-control study conducted at hospitals in Cayenne and Saint-Laurent du Maroni. Participants include patients with diagnosed diabetic peripheral neuropathy or chronic idiopathic axonal polyneuropathy, and a control group of hospital patients without neuropathy. At the initial visit, blood, urine, and hair samples will be collected to test for arbovirus antibodies and measure heavy metals like mercury and lead. Participants will also complete a questionnaire about their use of traditional plants. Participants will not have follow-up visits as part of the study. The main outcome measured is the comparison of exposure rates to these environmental factors between the case and control groups. Additional assessments include identifying genetic mutations and determining peripheral nerve disability at the time of enrollment. The study will help understand environmental risks that might explain unexplained cases of PN in this region.
CONDITIONS
Brief Title
Environmental Factors Associated With Peripheral Neuropathies in French Guiana
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with diabetic peripheral neuropathy or chronic idiopathic axonal polyneuropathy (Case group)
- Patients hospitalized or consulting at hospitals in Cayenne and Saint-Laurent du Maroni without peripheral neuropathy (Control group)
- Age 18 years or older
- Ability to complete the study questionnaire
- Willingness to participate without objection
You will not qualify if you...
- Under 18 years of age
- Objecting to participation
- Unable to complete the questionnaire
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants provide blood, urine, and hair samples and complete a questionnaire about plant consumption to assess environmental exposures related to peripheral neuropathies.
1 visit (in-person)
Trial Site Locations
Total: 2 locations
1
Centre Hospitalier de Cayenne
Cayenne, French Guiana, 97300
Actively Recruiting
2
Centre Hospitalier de l'Ouest Guyanais
Saint-Laurent-du-Maroni, French Guiana, 97320
Actively Recruiting
Research Team
N
Nathalie DESCHAMPS, Principal Investigator
V
Vincent De Paul SENEKIAN, Principal Investigator
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1